Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)

This study has suspended participant recruitment.
(lack of new patients)
Sponsor:
Information provided by:
Hospital Felicio Rocho
ClinicalTrials.gov Identifier:
NCT00832403
First received: January 27, 2009
Last updated: January 29, 2009
Last verified: January 2009
  Purpose

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.


Condition Intervention
Atrophic Rhinitis
Other: implants of polytetrafluoroethylene in tha nasal fossa

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Gore Tex Implants in the Treatment of Atrophic Rhinitis

Further study details as provided by Hospital Felicio Rocho:

Primary Outcome Measures:
  • improvement of fetid crusts and atrophy of the mucous bone covering [ Time Frame: after surgery recovery ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • lack of side effects such as infection [ Time Frame: after the treatment ] [ Designated as safety issue: No ]

Enrollment: 5
Study Start Date: November 2006
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
polytetrafluoroethylene Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa

Detailed Description:

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients that were submit to surgery to treat atrophic rhinitis with implants in the nasal fossa.

Criteria

Inclusion Criteria:

  • Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria:

  • Patients with mental illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Larissa Oliveira Lauriano, Hospital Felício Rocho
ClinicalTrials.gov Identifier: NCT00832403     History of Changes
Other Study ID Numbers: Rinite Atrófica cep/hfr
Study First Received: January 27, 2009
Last Updated: January 29, 2009
Health Authority: Brazil: Ministry of Health

Keywords provided by Hospital Felicio Rocho:
atrophic rhinitis
implants
Polytetrafluoroethylene

Additional relevant MeSH terms:
Atrophy
Rhinitis
Rhinitis, Atrophic
Nose Diseases
Otorhinolaryngologic Diseases
Pathological Conditions, Anatomical
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on October 21, 2014